Budweiser looks at marijuana. AB InBev, the world beer giant that also includes Stella Artois and Bud Light, allies with the Canadian cannabis giant Tilray to carry out research on "grass" drinks. The alliance, at least for now, will only concern Canada, the world's first major economy to legalize marijuana. And it will involve a total investment by the two companies of 100 million dollars, destined to research for non-alcoholic beverages containing cannabis.
The partnership gives wings to Tilray titles, which jump of 6.04%: the alliance is seen as yet another confirmation of the boom in the marijuana industry to which a growing number of traditional companies faces, seeing great potential . "In Tilray we have been carrying out research and development on different aspects of cannabis for almost five years", says Tilray CEO Brendan Kennedy, who believes that the alliance's goal is to understand how to create and produce "beverages and brands" "To cannabis.
2018 is proving to be a historic year for the Canadian company that, in a first position, has been listed on Wall Street as the first 'pure' producer of marijuana and the first to raise capital with a listing on an American list. In recent days, it has revealed a distribution agreement with the pharmaceutical giant Novartis. And now the alliance with the world's first beer producer. AB InBev has been keeping an eye on the cannabis market for some time but has moved, according to some sources reported in the American press, with greater caution than its rivals fearing a negative effect on its reputation from a possible landing in the marijuana industry.
In recent months there has been a real "grass" race. Constellation Brands, the brewer of Corona beer, announced in August a $ 4 billion investment in Canadian Canopy Growth, which aims to develop medical and recreational cannabis-based products for Canada and other markets. The Molson Coors beer has always been allied with the Canadian Hydropothecary for the development of non-alcoholic beverages with cannabis.